Functional screening revealed that knockout of PHGDH, PSAT1, SLC1A5 and SLC38A2 significantly impaired the survival of CRC cell lines, including those harbouring TP53, KRAS or BRAF mutations (Figure S12A–D). This evidence concerns the gene KRAS and colorectal carcinoma.